See more : IZON Network, Inc. (IZNN) Income Statement Analysis – Financial Results
Complete financial analysis of Chularat Hospital Public Company Limited (CHG.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chularat Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Taiwan Fructose Co., Ltd. (4207.TWO) Income Statement Analysis – Financial Results
- Dong-Ah Geological Engineering Company Ltd. (028100.KS) Income Statement Analysis – Financial Results
- Tatung Fine Chemicals Co. (4738.TWO) Income Statement Analysis – Financial Results
- Ubright Optronics Corporation (4933.TWO) Income Statement Analysis – Financial Results
- Canuc Resources Corporation (CNUCF) Income Statement Analysis – Financial Results
Chularat Hospital Public Company Limited (CHG.BK)
About Chularat Hospital Public Company Limited
Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand. It operates through two segments, Hospital Operations and Other Businesses. The company also distributes medical instruments and dietary supplement products. As of December 31, 2021, it operated 14 branches of clinics and hospitals. The company was founded in 1986 is headquartered in Samut Prakan, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.73B | 10.10B | 11.74B | 5.43B | 5.17B | 4.41B | 3.88B | 3.64B | 3.15B | 2.67B | 2.22B | 1.86B | 1.42B |
| Cost of Revenue | 5.72B | 5.91B | 5.88B | 3.68B | 3.63B | 3.07B | 2.63B | 2.47B | 2.08B | 1.76B | 1.45B | 1.20B | 983.45M |
| Gross Profit | 2.01B | 4.20B | 5.86B | 1.75B | 1.54B | 1.33B | 1.24B | 1.17B | 1.07B | 915.68M | 775.05M | 665.32M | 433.78M |
| Gross Profit Ratio | 25.97% | 41.52% | 49.90% | 32.18% | 29.74% | 30.29% | 32.06% | 32.12% | 34.00% | 34.27% | 34.89% | 35.71% | 30.61% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 910.77M | 934.88M | 821.27M | 673.20M | 672.38M | 570.07M | 550.85M | 493.82M | 425.89M | 359.33M | 287.25M | 237.14M | 197.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 910.77M | 934.88M | 821.27M | 673.20M | 672.38M | 570.07M | 550.85M | 493.82M | 425.89M | 359.33M | 287.25M | 237.14M | 197.26M |
| Other Expenses | 0.00 | -304.57M | -257.29M | -28.86M | -22.09M | 20.36M | 18.17M | 18.14M | 16.47M | 23.24M | 12.67M | 11.24M | 10.32M |
| Operating Expenses | 910.77M | 630.31M | 563.98M | 644.34M | 650.28M | 549.70M | 532.68M | 475.68M | 409.43M | 336.08M | 274.57M | 225.89M | 186.93M |
| Cost & Expenses | 6.63B | 6.54B | 6.45B | 4.33B | 4.28B | 3.62B | 3.17B | 2.94B | 2.49B | 2.09B | 1.72B | 1.42B | 1.17B |
| Interest Income | 8.66M | 6.08M | 1.90M | 2.77M | 3.16M | 3.49M | 2.46M | 2.97M | 7.44M | 19.84M | 20.48M | 713.08K | 0.00 |
| Interest Expense | 24.00M | 16.28M | 21.38M | 35.64M | 40.45M | 23.72M | 15.87M | 9.52M | 809.89K | 1.17M | 1.90M | 1.51M | 2.81M |
| Depreciation & Amortization | 440.57M | 381.78M | 351.06M | 353.53M | 328.85M | 275.14M | 254.35M | 212.23M | 164.43M | 135.93M | 110.86M | 101.78M | 97.66M |
| EBITDA | 1.81B | 3.95B | 5.65B | 1.46B | 1.22B | 1.06B | 966.82M | 907.74M | 835.19M | 735.36M | 631.80M | 541.06M | 344.64M |
| EBITDA Ratio | 23.43% | 39.11% | 48.11% | 26.88% | 23.60% | 24.16% | 24.97% | 24.99% | 26.47% | 27.52% | 28.44% | 29.04% | 24.32% |
| Operating Income | 1.38B | 3.56B | 5.30B | 1.10B | 889.12M | 785.25M | 710.01M | 692.55M | 663.32M | 579.59M | 500.48M | 439.43M | 246.84M |
| Operating Income Ratio | 17.87% | 35.28% | 45.10% | 20.32% | 17.21% | 17.82% | 18.32% | 19.04% | 21.02% | 21.69% | 22.53% | 23.59% | 17.42% |
| Total Other Income/Expenses | -34.70M | -11.30M | -19.48M | -32.87M | -37.28M | -20.23M | -13.41M | -6.55M | 6.63M | 18.67M | 18.55M | -866.18K | -2.67M |
| Income Before Tax | 1.35B | 3.55B | 5.28B | 1.07B | 848.67M | 765.02M | 696.60M | 685.99M | 669.95M | 598.26M | 519.03M | 437.77M | 244.17M |
| Income Before Tax Ratio | 17.42% | 35.17% | 44.93% | 19.72% | 16.43% | 17.36% | 17.97% | 18.86% | 21.24% | 22.39% | 23.36% | 23.50% | 17.23% |
| Income Tax Expense | 279.09M | 703.37M | 1.01B | 218.73M | 184.00M | 149.80M | 130.82M | 121.01M | 131.62M | 117.57M | 104.65M | 102.75M | 72.69M |
| Net Income | 1.05B | 2.78B | 4.20B | 876.62M | 705.24M | 633.88M | 565.44M | 564.29M | 538.38M | 480.62M | 414.38M | 335.01M | 171.48M |
| Net Income Ratio | 13.53% | 27.50% | 35.80% | 16.14% | 13.65% | 14.38% | 14.59% | 15.52% | 17.06% | 17.99% | 18.65% | 17.98% | 12.10% |
| EPS | 0.10 | 0.25 | 0.38 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 |
| EPS Diluted | 0.10 | 0.25 | 0.38 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.02 |
| Weighted Avg Shares Out | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 10.20B | 8.80B | 8.80B |
| Weighted Avg Shares Out (Dil) | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B | 10.20B | 8.80B | 8.80B |
Source: https://incomestatements.info
Category: Stock Reports